LOANS (COVID-19 Loan Modifications) (Details) $ in Millions |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2021
USD ($)
loan
|
Dec. 31, 2020
USD ($)
loan
|
|
| Financing Receivable, Impaired [Line Items] | ||
| Financing Receivable, Modifications, Number of Contracts | loan | 0 | 0 |
| COVID 19 - Impact | ||
| Financing Receivable, Impaired [Line Items] | ||
| Financing Receivable, Modifications, Number of Contracts | loan | 8 | 63 |
| Loan Restructuring, Trial Modifications, Amount | $ 48.9 | $ 220.3 |
| Percentage of Loans and Leases Receivable, Modified | 1.31% | 7.00% |
| COVID 19 - Impact | Principal Payment Deferrals | ||
| Financing Receivable, Impaired [Line Items] | ||
| Loan Restructuring, Trial Modifications, Amount | $ 39.1 | $ 121.4 |
| Percentage of Loans and Leases Receivable, Modified | 1.05% | 3.87% |
| COVID 19 - Impact | Full Payment Deferrals | ||
| Financing Receivable, Impaired [Line Items] | ||
| Loan Restructuring, Trial Modifications, Amount | $ 9.9 | $ 98.9 |
| Percentage of Loans and Leases Receivable, Modified | 0.26% | 3.19% |